WEI Xin, LIU Xia, SHI Lin, YUN Fen, JIA Yongfeng. Effect of fucosyltransferase 8 expression on immunecell infiltration and survival prognosis in breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 76-81, 87. DOI: 10.7619/jcmp.20211784
Citation: WEI Xin, LIU Xia, SHI Lin, YUN Fen, JIA Yongfeng. Effect of fucosyltransferase 8 expression on immunecell infiltration and survival prognosis in breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 76-81, 87. DOI: 10.7619/jcmp.20211784

Effect of fucosyltransferase 8 expression on immunecell infiltration and survival prognosis in breast cancer

More Information
  • Received Date: April 27, 2021
  • Available Online: August 31, 2021
  • Published Date: September 14, 2021
  •   Objective   To investigate the relationship between fucosyltransferase 8(FUT8)and immune cell infiltration in breast cancer and its impact on prognosis.
      Methods   The expression of FUT8 in breast cancer as well as other types of cancer was retrieved and analyzed using the Tumor Immunoassay database (TIMER) and Oncomine database; survival curves was plotted by Kaplan-Meier Plotter database and the effects of FUT8 under different clinical characteristics on the prognosis of breast cancer patients were summarized; the association between FUT8 and immune cell infiltration in breast cancer was investigated by TIMER and TIMER2.0; TIMER2.0 and bc-GenExMiner database were used to derive the correlations between FUT8 and immune cell markers, immune checkpoints in breast cancer; finally, immunohistochemical staining was conducted to detect the expression of FUT8 in breast cancer.
      Results   FUT8 was expressed in 85% of breast cancer tissues, and high levels of FUT8 leaded to better survival and prognosis in most patients (HR < 1). In the basal subtype, the levels of FUT8 were positively correlated with infiltration of CD8+T cells, Treg cells, NK cells and macrophages; in the HER2 + subtype, the levels of FUT8 were positively correlated with infiltration of CD4+T cells and Treg cells; in basal and HER2 subtypes, FUT8 expression was positively correlated with most immune checkpoints and immune cell markers.
      Conclusion   FUT8 has important roles in evaluating the prognosis and the level of immune cell infiltration in breast cancer patients.
  • [1]
    LI J, GAO C, LIU C, et al. Four lncRNAs associated with breast cancer prognosis identified by coexpression network analysis[J]. J Cell Physiol, 2019, 234(8): 14019-14030. doi: 10.1002/jcp.28089
    [2]
    LI F, ZHAO S, CUI Y, et al. α1, 6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC)[J]. Am J Cancer Res, 2020, 10(3): 816-837.
    [3]
    TU C F, WU M Y, LIN Y C, et al. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation[J]. Breast Cancer Res, 2017, 19(1): 111. doi: 10.1186/s13058-017-0904-8
    [4]
    LI T, FAN J, WANG B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res, 2017, 77(21): e108-e110. doi: 10.1158/0008-5472.CAN-17-0307
    [5]
    JJÉZÉQUEL P, GOURAUD W, BEN AZZOUZ F, et al. bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses[J]. Database (Oxford), 2021, 2021.
    [6]
    AGRAWAL P, FONTANALS-CIRERA B, SOKOLOVA E, et al. A systems biology approach identifies FUT8 as a driver of melanoma metastasis[J]. Cancer Cell, 2017, 31(6): 804-819. doi: 10.1016/j.ccell.2017.05.007
    [7]
    XIANG T, YANG G, LIU X, et al. Alteration of N-glycan expression profile and glycan pattern of glycoproteins in human hepatoma cells after HCV infection[J]. Biochim Biophys Acta Gen Subj, 2017, 1861(5 pt a): 1036-1045. http://www.onacademic.com/detail/journal_1000039821081510_57b1.html
    [8]
    QUAIL D F, JOYCE J A. Microenvironmental regulation of tumor progression and metastasis[J]. Nat Med, 2013, 19(11): 1423-1437. doi: 10.1038/nm.3394
    [9]
    NGAMBENJAWONG C, GUSTAFSON H H, PUN S H. Progress in tumor-associated macrophage (TAM)-targeted therapeutics[J]. Adv Drug Deliv Rev, 2017, 114: 206-221. doi: 10.1016/j.addr.2017.04.010
    [10]
    FREY D M, DROESER R A, VIEHL C T, et al. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients[J]. Int J Cancer, 2010, 126(11): 2635-2643.
    [11]
    DE SIMONE M, ARRIGONI A, ROSSETTI G, et al. Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells[J]. Immunity, 2016, 45(5): 1135-1147. doi: 10.1016/j.immuni.2016.10.021
    [12]
    O′DONNELL J S, MADORE J, LI X Y, et al. Tumor intrinsic and extrinsic immune functions of CD155[J]. Semin Cancer Biol, 2020, 65: 189-196. doi: 10.1016/j.semcancer.2019.11.013
    [13]
    SANCHEZ-CORREA B, VALHONDO I, HASSOUNEH F, et al. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy[J]. Cancers (Basel), 2019, 11(6): 877. doi: 10.3390/cancers11060877
    [14]
    MAHNKE K, ENK A H. TIGIT-CD155 interactions in melanoma: a novel Co-inhibitory pathway with potential for clinical intervention[J]. J Invest Dermatol, 2016, 136(1): 9-11. doi: 10.1016/j.jid.2015.10.048

Catalog

    Article views (364) PDF downloads (18) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return